Home Xenon Pharma

Xenon Pharma

In operation
Seasoned Equity Offering
Developer of Therapeutic Drugs for Neurological Disorders

Basic Information

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies to improve the lives of patients with neurological disorders. We are advancing a novel pipeline of therapies focused on neurology to address areas of high unmet medical need, with an emphasis on epilepsy. We believe we have developed core competencies in identifying and developing selective small molecule ion channel modulators, and we believe we can leverage this expertise to develop a range of novel ion channel inhibitors for diseases in areas of high unmet medical need. Additionally, we complement our internal discovery capabilities by identifying external product candidates targeting CNS ion channels for the treatment of neurological disorders.
Xenon Pharmaceuticals, Inc.
Burnaby,BritishColumbia,Canada
101~500 people
January 01, 1996
investors@xenon-pharma.com